EUVIMEDOpdag EUVIMED
Qualitative StudieOpen access · CC BY-NC-ND 4.0

Long-term experiences of patients prescribed medicinal cannabis in Australia: a qualitative interview study

Margaret-Ann Tait, Kate White, Claudia Rutherford, Daniel S J Costa, Rachel Campbell

Australian Journal of Primary Health · 2026-08-17 · 32 (4)

DOI: 10.1071/py25229 ↗

At a glance

Qualitative Studie in Australian Journal of Primary Health, published online on 2026-08-11. Written by Margaret-Ann Tait and 4 co-authors. Institution: The University of Sydney, Faculty of Medicine and Health, Susan Wakil School of Nursing and Midwifery, Sydney, NSW 2006, Australia. Major MEDLINE topics: Medical Marijuana. 43 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

There is limited, but emerging, evidence supporting the use of medicinal cannabis (MC) to manage pain, anxiety, spasticity, insomnia and depression. Although Australian legislation changed in 2016 to provide access to unapproved MC products, clinical guidance on prescribing MC is limited because it is still mostly an unapproved therapy accessed under strict conditions. Since legislation changed, little is known about the long-term lived experience of patients being prescribed unapproved MC products in Australia. We aimed to explore, and obtain an in depth understanding of, the long-term experiences of patients prescribed MC.

Methods

Using an interpretive qualitative approach, participants were recruited from the Quality-of-Life Evaluation Study, a nationwide longitudinal study of patients with any chronic health condition prescribed orally administered MC oil over 1 year. Semi-structured interviews explored experiences of accessing and using MC during and since completing the Quality-of-Life Evaluation Study. Thematic analysis identified themes and subthemes from the data.

Results

Fifteen participants aged 33–78 years (nine female) who had completed the Quality-of-Life Evaluation Study and renewed MC oil prescriptions within the previous 6 months to manage chronic pain, insomnia, muscle spasticity, anxiety or depression were interviewed. Analysis identified four overarching themes: ‘This isn’t living’; ‘I was looking for a solution’; ‘It wasn’t to get high’; and ‘Everything’s much better’, and eight subthemes covering concerns, barriers, patient autonomy and benefits. Participants commonly used MC to reduce or replace conventional medications taken for their conditions, and viewed MC as a low-risk ‘natural’ alternative. Barriers to accessing MC included difficulties obtaining prescriptions and the cost of MC products. Participants reported symptom improvements that flowed on to benefit relationships, productivity and mental health over the long term. Although initially concerned about side-effects, participants self-managed these effectively, with perceived benefits outweighing side-effects. Participants described roadside drug testing as an ongoing concern.

Conclusions

This group of patients prescribed orally administered MC oil in Australia reported many benefits of MC, but faced ongoing barriers to MC access. Improved awareness and education, simplified prescribing processes, and less prohibitive driving laws could lead to wider acceptance of MC as a therapeutic option and improved patient-centred care.

Subjects

MeSH terms (MEDLINE)

Medical MarijuanaHumansFemaleAustraliaAdultMaleMiddle AgedAgedQualitative ResearchQuality of LifeLongitudinal StudiesInterviews as TopicAnxietyChronic PainChronic DiseaseDepression

Author keywords

chronic conditionsinterviewsmedicinal cannabispatient-centred carequalitative researchself-management

Substances

Medical Marijuana

Authors and institutions

  • The University of Sydney, Faculty of Medicine and Health, Susan Wakil School of Nursing and Midwifery, Sydney, NSW 2006, Australia.
  • The University of Sydney, Faculty of Science, School of Psychology, Sydney, NSW 2006, Australia.

Cite

APA

Tait, M. A., White, K., Rutherford, C., Costa, D. S. J., & Campbell, R. (2026). Long-term experiences of patients prescribed medicinal cannabis in Australia: a qualitative interview study. Australian Journal of Primary Health, 32(4). https://doi.org/10.1071/py25229

Vancouver

Tait MA, White K, Rutherford C, Costa DSJ, Campbell R. Long-term experiences of patients prescribed medicinal cannabis in Australia: a qualitative interview study. Australian Journal of Primary Health. 2026;32(4). doi:10.1071/py25229

BibTeX
@article{Tait2026,
  author = {Tait, Margaret-Ann and White, Kate and Rutherford, Claudia and Costa, Daniel S J and Campbell, Rachel},
  title = {Long-term experiences of patients prescribed medicinal cannabis in Australia: a qualitative interview study},
  journal = {Australian Journal of Primary Health},
  year = {2026},
  volume = {32},
  number = {4},
  doi = {10.1071/py25229}
}
Start for free →